ライフサイエンスコーパス: popliteal artery

1 t to the pulsatility index (PI) value of the popliteal artery.

2 class 2 to 5 who had a de novo lesion in the popliteal artery.

3 lar treatment for obstructive lesions of the popliteal artery.

4 odium chloride (SALINE) was infused into the popliteal artery.

5 atients had stenoses or occlusions below the popliteal artery.

6 n, plasmid DNA was transferred to the distal popliteal artery.

7 rtery disease of the superficial femoral and popliteal arteries.

8 flow (mean vessel sharpness: 44% vs 30% for popliteal arteries, 45% vs 28% for saphenous arteries; P

9 cond and first order arterioles vs. feed and popliteal arteries (58% and 16% vs. 5% and 3%; N = 10 im

10 ent placement for obstructive lesions of the popliteal artery achieves superior acute technical succe

11 surement of oxygen saturation in the femoral/popliteal arteries and veins during cuff-induced reactiv

12 U in the midabdominal aorta to 357 HU in the popliteal artery and 253 HU in the dorsalis pedis or pos

13 with additional 5 seconds +/- 2 to reach the popliteal artery and 7 seconds +/- 4 to reach the ankle

14 The relationship between PI values of the popliteal artery and the number of thrombosed calf veins

15 n 5 cm in the superficial femoral artery and popliteal artery, and six patients had stenoses or occlu

16 y words were: "superficial femoral artery," "popliteal artery," "angioplasty," "drug-eluting balloon,

17 tion, the superficial femoral artery and the popliteal artery are subject to various forces e.g. thos

18 tentially associated with the development of popliteal artery atherosclerosis in a population-based s

19 h subsequently augmented insulin-stimulated popliteal artery blood flow and muscle perfusion.

20 with symptomatic superficial femoral and/or popliteal artery disease at 11 German centers between Se

21 ndovascular treatment of superficial femoral-popliteal artery disease in the Society for Vascular Sur

22 ality after treatment of superficial femoral-popliteal artery disease with paclitaxel and nonpaclitax

23 tment of symptomatic superficial femoral and popliteal artery disease.

24 stress reaction, periostitis, claudication, popliteal artery entrapment, and peripheral nerve entrap

25 andomization, included the ICD and ACD, ABI, popliteal artery flow with duplex and QOL* at baseline*,

26 udication distances, pressure indices [ABI], popliteal artery flow, and QOL with the short-form 36 He

27 Brachial and popliteal artery FMD and DC did not change in control su

28 Similarly, popliteal artery FMD increased from baseline (6.2 +/- 0.

29 based therapy in the superficial femoral and popliteal arteries in patients with peripheral artery di

30 Patients with popliteal artery injuries over the 10-year period ending

31 ve patients who sustained iliac, femoral, or popliteal artery injuries, and underwent surgery to atte

32 e limb salvage in association with repair of popliteal artery injuries.

33 accepted factors impacting amputation after popliteal artery injury include blunt trauma, prolonged

34 ed to evaluate those factors associated with popliteal artery injury that influence amputation, with

35 of Comprehensive Superficial Femoral and/or Popliteal Artery Lesions Using the IN.PACT Admiral Drug-

36 e Superficial Femoral Artery and/or Proximal Popliteal Artery [MDT-2113 SFA], NCT01947478; The IN.PAC

37 luding superficial femoral, deep femoral and popliteal) artery models that were reconstructed from ma

38 or arterial remodelling, in the brachial and popliteal arteries of 13 healthy male subjects (21.6 +/-

39 ated spectral doppler characteristics of the popliteal artery on the same side as the isolated calf v

40 uperficial Femoral Artery [SFA] and Proximal Popliteal Artery [PPA] [INPACT SFA II], NCT01566461; MDT

41 rficial Femoral Artery [SFA] and/or Proximal Popliteal Artery [PPA]) that enrolled 331 subjects with

42 To investigate the usefulness of popliteal artery spectral doppler findings as a complime

43 Popliteal arteries, subsequent gastrocnemius feed arteri

44 e Superficial Femoral Artery and/or Proximal Popliteal Artery Using the IN.PACT Admiral(TM) Drug-Elut

45 The WSS in the narrow popliteal artery was more sensitive to a reduction in ra

46 tment of Superficial Femoral and/or Proximal Popliteal Artery) was designed to evaluate the patency o

47 ystem in which only the common iliac through popliteal arteries were considered.

48 Lesions above the popliteal artery were a significant predictor of residua

49 ative superficial femoral artery or proximal popliteal artery with stenosis >=70%, vessel diameter of